Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEP Chemotherapy with Stem Cell Rescue for Relapsed/Refractory Hodgkin's Disease
NCT00002522Phase 2Completed
- Sponsor
- Temple University
- Start
- Feb 1993
- Primary completion
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, cyclophosphamide, etoposide in Hodgkin lymphoma (HL), sponsored by Temple University. Started Feb 1993; status: completed.
02
Drugs
cisplatincyclophosphamideetoposide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00002522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002522.